Qube Research & Technologies (QRT)’s VanEck Biotech ETF BBH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.51K	Hold	24	–	–	﹤0.01%	3393
2025 Q4	$4.54K	Hold	24	–	–	﹤0.01%	3526
2025 Q3	$3.98K	Hold	24	–	–	﹤0.01%	3433
2025 Q2	$3.68K	Hold	24	–	–	﹤0.01%	3422
2025 Q1	$3.78K	Hold	24	–	–	﹤0.01%	3368
2024 Q4	$3.77K	Hold	24	–	–	﹤0.01%	3328
2024 Q3	$4.26K	Hold	24	–	–	﹤0.01%	3121
2024 Q2	$4.04K	Hold	24	–	–	﹤0.01%	3085
2024 Q1	$3.99K	Hold	24	–	–	﹤0.01%	3918
2023 Q4	$3.97K	Hold	24	–	–	﹤0.01%	3750
2023 Q3	$3.74K	Sell	24 -62,144	-100%	-$9.93M	﹤0.01%	3493
2023 Q2	$9.47M	Buy	62,168 +62,005	+38,040%	+$9.91M	0.03%	549
2023 Q1	$26.4K	Sell	163 -306	-65%	-$49.5K	﹤0.01%	2280
2022 Q4	$74.9K	Sell	469 -577	-55%	-$91.4K	﹤0.01%	2069
2022 Q3	$147K	Buy	1,046 +805	+334%	+$122K	﹤0.01%	1862
2022 Q2	$35K	Buy	+241	New	+$35.9K	﹤0.01%	2184
2022 Q1	–	Sell	-1	Closed	–	–	2447
2021 Q4	$0	Sell	1 -563	-100%	-$109K	﹤0.01%	2524
2021 Q3	$114K	Buy	564 +153	+37%	+$32.1K	﹤0.01%	1769
2021 Q2	$83K	Buy	+411	New	+$76.5K	﹤0.01%	1973

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BBH Position: Q1 2026 in Review

Qube Research & Technologies (QRT) held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 24 shares worth $4.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3393.

Qube Research & Technologies (QRT) first reported a position in BBH in Q2 2021 and has held it in 19 quarters since. The position peaked at $9.47M in Q2 2023. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Qube Research & Technologies (QRT) held 24 shares of VanEck Biotech ETF worth $4.51K as of Q1 2026.
Qube Research & Technologies (QRT) left its VanEck Biotech ETF share count unchanged in Q1 2026.
VanEck Biotech ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #3393 holding.
Qube Research & Technologies (QRT) first reported a position in VanEck Biotech ETF in Q2 2021 and has held it in 19 quarters since.
Qube Research & Technologies (QRT)'s VanEck Biotech ETF position peaked at $9.47M in Q2 2023.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.